Randomized phase III study of taxane versus TS-1 as first-line treatment for metastatic breast cancer (SELECT BC).
Fumikata Hara
Honoraria - Sanofi ; Taiho Pharmaceutical
Nobuaki Matsubara
No relevant relationships to disclose
Tsuyoshi Saito
No relevant relationships to disclose
Toshimi Takano
Honoraria - Bristol-Myers Squibb; Sanofi ; Taiho Pharmaceutical
Youngjin Park
No relevant relationships to disclose
Tatsuya Toyama
No relevant relationships to disclose
Yasuo Hozumi
Honoraria - Sanofi ; Taiho Pharmaceutical
Research Funding - Sanofi ; Taiho Pharmaceutical
Junji Tsurutani
No relevant relationships to disclose
Shigeru Imoto
No relevant relationships to disclose
Tsutomu Takashima
Honoraria - Taiho Pharmaceutical
Takanori Watanabe
No relevant relationships to disclose
Yoshiaki Sagara
No relevant relationships to disclose
Reiki Nishimura
Honoraria - Taiho Pharmaceutical
Yasuo Ohashi
Employment or Leadership Position - Statcom
Stock Ownership - Statcom
Honoraria - Chugai Pharma; Sanofi ; Shionogi
Research Funding - Astellas Pharma; Kyowa Hakko Kirin; Takeda
Hirofumi Mukai
Honoraria - Bristol-Myers Squibb; Sanofi ; Taiho Pharmaceutical